All In MedTech

Device Trial Radar · NCT04012944

SIRONA 2 Trial Heart Failure NYHA Class III

A Prospective, Multi-Center, Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (SIRONA 2 Trial)

Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

81

Actual

Start

Jun 26, 2019

Primary completion

Oct 30, 2021

Study completion Dec 2031

Sponsor

Lead sponsor
Endotronix, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 9, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Cordella PA Sensor System in up to 75 New York Heart Association (NYHA) Class III Heart Failure patients who will receive the Cordella PA Sensor Implant.

Conditions

  • Heart Failure NYHA Class III

Interventions

  • Cordella™ Pulmonary Artery Sensor SystemDevice

    The Cordella PA Sensor System comprises seven subsystems that operate together to take daily Pulmonary Artery Pressure (PAP) readings at a patient's home and transmit the results to a care provider for evaluation. 1. Cordella Sensor 2. Cordella Delivery System 3. myCordella Patient Reader 4. Reader Dock 5. Cordella Calibration Equipment (CalEQ) 6. myCordella Hub 7. Cordella Data Analysis Platform (CDAP).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Freedom from Adverse EventsTime frame: 30 days
  2. Accuracy of Cordella PA Sensor System pressure measurements, compared to standard-of-care fluid-filled catheter PA pressure measurements obtained by standard Right Heart Catheterization (RHC)Time frame: 90 days

Locations

7 sites in 3 countries. Site status is shown where the registry gives one.

  • Cardivascular Center OLV Aalst

    Aalst, Belgium

  • Ziekenhuis- Oost Limburg

    Genk, Belgium

  • Uniklinik Köln, Klinik III für Innere Medizin Herzzentrum der Universität zu Köln

    Cologne, Germany

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.